| Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn′ s disease N Inohara, Y Ogura, A Fontalba, O Gutierrez, F Pons, J Crespo, K Fukase, ... Journal of Biological Chemistry 278 (8), 5509-5512, 2003 | 2220 | 2003 |
| Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells R Catlett-Falcone, TH Landowski, MM Oshiro, J Turkson, A Levitzki, ... Immunity 10 (1), 105-115, 1999 | 2156 | 1999 |
| Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-κB activation O Gutierrez, C Pipaon, N Inohara, A Fontalba, Y Ogura, F Prosper, ... Journal of Biological Chemistry 277 (44), 41701-41705, 2002 | 564 | 2002 |
| Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5–dependent … M Horita, EJ Andreu, A Benito, C Arbona, C Sanz, I Benet, F Prosper, ... The Journal of experimental medicine 191 (6), 977-984, 2000 | 513 | 2000 |
| Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2 M Silva, D Grillot, A Benito, C Richard, G Nunez, JL Fernandez-Luna | 460 | 1996 |
| Erythropoietin can induce the expression of bcl-xlthrough stat5 in erythropoietin-dependent progenitor cell lines M Silva, A Benito, C Sanz, F Prosper, D Ekhterae, G Nunez, ... Journal of Biological Chemistry 274 (32), 22165-22169, 1999 | 421 | 1999 |
| Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells PJ Real, A Sierra, A De Juan, JC Segovia, JM Lopez-Vega, ... Oncogene 21 (50), 7611-7618, 2002 | 403 | 2002 |
| Cannabinoid receptors as novel targets for the treatment of melanoma C Blázquez, A Carracedo, L Barrado, P José Real, ... The FASEB journal 20 (14), 2633-2635, 2006 | 342 | 2006 |
| Expression of Bcl-x in erythroid precursors from patients with polycythemia vera M Silva, C Richard, A Benito, C Sanz, I Olalla, JL Fernández-Luna New England Journal of Medicine 338 (9), 564-571, 1998 | 322 | 1998 |
| Selective Induction of Apoptosis in Cancer Cells by the Ether Lipid ET-18-OCH3 (Edelfosine): Molecular Structure Requirements, Cellular Uptake, and Protection by Bcl-2 and … F Mollinedo, JL Fernández-Luna, C Gajate, B Martín-Martín, A Benito, ... Cancer research 57 (7), 1320-1328, 1997 | 284 | 1997 |
| Expression and functional role of nitric oxide synthase in osteoblast‐like cells JA Riancho, E Salas, MT Zarrabeitia, JM Olmos, JA Amado, ... Journal of Bone and Mineral Research 10 (3), 439-446, 1995 | 254 | 1995 |
| Characterization of 8p21. 3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes F Rubio-Moscardo, D Blesa, C Mestre, R Siebert, T Balasas, A Benito, ... Blood 106 (9), 3214-3222, 2005 | 250 | 2005 |
| The NFκB pathway: a therapeutic target in glioblastoma L Nogueira, P Ruiz-Ontañon, A Vazquez-Barquero, F Moris, ... Oncotarget 2 (8), 646, 2011 | 154 | 2011 |
| Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-XL A Benito, M Silva, D Grillot, G Nunez, JL Fernandez-Luna Blood 87 (9), 3837-3843, 1996 | 152 | 1996 |
| Identification of two regions within the cytoplasmic domain of the human interferon-gamma receptor required for function. MA Farrar, J Fernandez-Luna, RD Schreiber Journal of biological chemistry 266 (29), 19626-19635, 1991 | 150 | 1991 |
| Cloning and expression of the cDNA for the murine interferon gamma receptor. PW Gray, S Leong, EH Fennie, MA Farrar, JT Pingel, J Fernandez-Luna, ... Proceedings of the National Academy of Sciences 86 (21), 8497-8501, 1989 | 145 | 1989 |
| Breast cancer cells can evade apoptosis-mediated selective killing by a novel small molecule inhibitor of Bcl-2 PJ Real, Y Cao, R Wang, Z Nikolovska-Coleska, J Sanz-Ortiz, S Wang, ... Cancer research 64 (21), 7947-7953, 2004 | 142 | 2004 |
| Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells. A Benito, D Grillot, G Nuñez, JL Fernández-Luna The American journal of pathology 146 (2), 481, 1995 | 131 | 1995 |
| NLRP2, an inhibitor of the NF-κB pathway, is transcriptionally activated by NF-κB and exhibits a nonfunctional allelic variant A Fontalba, O Gutierrez, JL Fernandez-Luna The Journal of Immunology 179 (12), 8519-8524, 2007 | 128 | 2007 |
| Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al VM Martinez‐Taboada, A Fontalba, R Blanco, JL Fernández‐Luna Arthritis & Rheumatism 52 (7), 2226-2227, 2005 | 118 | 2005 |
